If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giovanna Mansueto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Retrospective Studies Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Salvage Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

  • 772 Citations
  • 16 h-Index
  • 44 Article

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D’Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., Jan 1 2019, In : Annals of Hematology. 98, 10, p. 2329-2338

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Disease Progression

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D'Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., Oct 2019, In : Annals of Hematology. 98, 10, p. 2329-2338 10 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Disease Progression

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline

Crugnola, M., Castagnetti, F., Breccia, M., Ferrero, D., Trawinska, M. M., Abruzzese, E., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Bonifacio, M., Fava, C., Iurlo, A., Bucelli, C., Mansueto, G., Gozzini, A., Falzetti, F., Montefusco, E., Crisà, E., Gugliotta, G. & 24 others, Russo, S., Cedrone, M., RussoRossi, A., Pregno, P., Isidori, A., Mauro, E., Atelda, R., Giglio, G., Celesti, F., Sorà, F., Storti, S., D’Addosio, A., Galimberti, S., Orlandi, E., Calistri, E., Bocchia, M., Cavazzini, F., Rege Cambrin, G., Orofino, N., Luciano, L., Sgherza, N., Rosti, G., Latagliata, R. & Capodanno, I., 2019, In : Annals of Hematology.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Cytogenetics
Disease-Free Survival
Germany

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Oct 23 2018, In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D’Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Jan 1 2018, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations